ArticleFrontiers in nutrition2025
Exploring the association between vitamin D levels and dyslipidemia risk: insights from machine learning and generalized additive models.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Long-term effects of carbamazepine on bone-related biochemical markers in patients with epilepsy.Acta epileptologica · 2026Article
- Perioperative Cerebral Protection and Monitoring of Acute Stanford Type A Aortic Dissection: A Retrospective Cohort Study.Journal of cardiovascular development and disease · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vitamin D is a necessary nutrient that is important for calcium homeostasis and bone health. Dyslipidemia is thought to be a risk factor for the development of atherosclerotic illnesses. Recent research suggests that vitamin D may influence lipid metabolism, specifically the levels of circulating lipids in the blood. However, the relationship between vitamin D and dyslipidemia remains controversial, indicating a need for further research to clarify this association. Objectives: Data from 780 participants in the "Early Identification, Early Diagnosis Techniques, and Points of Risk for Diabetes in Major Chronic Non-communicable Disease Prevention and Control Studies" were analyzed. Methods: We employed machine learning with the XGboost algorithm, Least Absolute Shrinkage Selection Operator (LASSO) regression, and univariate logistic regression to screen variables. Subsequently, multiple logistic regression and a generalized additive model (GAM) were utilized to construct models analyzing the association between vitamin D levels and dyslipidemia. Results: In our study, the XGboost machine learning algorithm explored the relative importance of all included variables, confirming a robust association between vitamin D levels and dyslipidemia. After adjusting for all the important covariates, the results showed that the risk of dyslipidemia in vitamin D insufficiency group and vitamin D deficiency group was 2.11 times and 2.77 times of that in vitamin D sufficiency group, respectively. A smooth curve was constructed based on GAM and a significant negative association was found between 25(OH)D and the risk of dyslipidemia. Conclusion: There may be a negative association between 25(OH)D and the risk of dyslipidemia. Nonetheless, additional well-designed studies are necessary to substantiate this relationship.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.